The World Health Organization convened a high-level emergency meeting with government leaders and pharmaceutical company representatives earlier this week to discuss issues surrounding access to experimental Ebola vaccines.
Pfizer’s serotonin and norepinephrine reuptake inhibitor, desvenlafaxine (Pristiq), has low potential for causing sexual dysfunction in patients with major depressive disorder.
Xigduo XR combines 2 anti-hyperglycemic agents with complementary mechanisms of action.
Asthmatics with vitamin D deficiency are significantly more susceptible to acute asthma attacks.
Members of Congress have launched an investigation into the increasing generic drug prices that are plaguing both patients and pharmacists.
New recommendations for the removal of protective gear highlight the need for enhanced technologies.
Should CVS Caremark be allowed to charge patients more for buying their prescriptions at stores that sell tobacco?